New CEO to Swedish Tillotts Pharma
The Swiss company Tillotts Pharma's newly established Swedish organisation has appointed a CEO from Bayer Scandinavia.
Tillotts Pharma is focused on gastroenterology and stand behind the drug Asacol, used against intestine inflammations. The drug’s turnover in the Nordic countries is almost SEK 170 million. The new Nordic Tillotts Pharma will continue to focus on Asacol.
